Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00117481 | Evaluation of DR-2001 for the Management of Endometriosis-Related Pelvic Pain | PHASE2 | COMPLETED | 90 | — | — | Jun 1, 2005 | Dec 1, 2007 | May 9, 2014 | 41 | United States |
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | - |
| 2 | EXPERIMENTAL | - |
| 3 | PLACEBO_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| DR-2001a | DRUG | DR-2001a administered vaginally each month |
| DR-2001b | DRUG | DR-2001b administered vaginally each month |
| Placebo | OTHER | Placebo administered vaginally each month |
Inclusion Criteria: * Surgically sterilized (patient or partner), willing to use condoms throughout the study, or otherwise not at risk for pregnancy * Diagnosis of endometriosis within the last 5 years * Moderate or severe nonmenstrual pelvic pain * Premenopausal * Not pregnant or breastfeeding * ...